Author(s)

Jing Liu ¹, Ruilin Sun ¹

Affiliation(s)

¹ The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, 510317, China

Corresponding Author

Ruilin Sun

ABSTRACT

This review explores the emerging role of gut microbiota in lung cancer and Chronic Obstructive Pulmonary Disease (COPD), emphasizing the gut-lung axis's integral role in these diseases. Lung cancer, the leading cause of cancer-related mortality, and COPD, a prevalent chronic respiratory condition, share common risk factors and pathophysiological pathways that may be influenced by the gut microbiota. Through a synthesis of current research, this article highlights the differences in gut microbiota composition observed in patients with lung cancer and COPD compared to healthy individuals, and discusses the potential mechanisms by which these microbial populations might impact disease development and progression. The review also delves into the promising therapeutic implications of modulating gut microbiota, including dietary interventions, probiotics, prebiotics, and fecal microbiota transplantation, as adjunctive treatments for these respiratory diseases. Future research directions are proposed, focusing on the need for a deeper understanding of the gut-lung axis and the translation of these findings into clinical practice. This review underscores the significance of gut microbiota in respiratory diseases and points towards a new frontier in personalized medicine, where microbiome modulation could complement traditional treatment approaches.

KEYWORDS

Gut Microbiota, Lung Cancer, Chronic Obstructive Pulmonary Disease, Gut-Lung Axis, Microbiome

CITE THIS PAPER

Jing Liu, Ruilin Sun, Research progress of intestinal flora in lung cancer and chronic obstructive pulmonary disease. MEDS Clinical Medicine (2023) Vol. 4: 63-69. DOI: http://dx.doi.org/10.23977/medsc.2023.040909.

REFERENCES

[1] De Nuccio, F. et al. Gut–lung Microbiota interactions in chronic obstructive pulmonary disease (COPD): potential mechanisms driving progression to COPD and epidemiological data[J]. Lung, 2022, 200(6): 773-781.
[2] Song, W. et al. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: a review [J]. Biomedicine & Pharmacotherapy, 2023, 165: 115150.
[3] De Rubis, G. et al. Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease[J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023: 1-41.
[4] Wang, H. et al. The Function and Molecular Mechanism of Commensal Microbiome in Promoting Malignant Progression of Lung Cancer[J]. Cancers, 2022, 14(21): 5394.
[5] Lim, E. Y. et al. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease [J]. Journal of Microbiology and Biotechnology, 2023, 33(9): 1111.
[6] Ashique, S. et al. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases [J]. Chemico-Biological Interactions, 2022: 110231.
[7] Liu, Y. et al. The role of mitochondrial quality control in chronic obstructive pulmonary disease[J]. Laboratory Investigation, 2023: 100307.
[8] Li, N. et al. Gut Microbiota Dysbiosis and Chronic Obstructive Pulmonary Disease: A Question of Chicken and Egg [J]. American Journal of Respiratory and Critical Care Medicine, 2023, 208(11): 1238-1240.
[9] Tian, J. et al. Effect of hyperthermia on intestinal microecology, immune function, and progression-free survival in patients with advanced unresectable lung adenocarcinoma[J]. Scientific Reports, 2023, 13(1): 17223.
[10] Li, N. et al. The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease [J]. Frontiers in Microbiology, 2023, 14: 24-35.
[11] Prasanthan, T. A. et al. Deducing the Interplay between Gut Flora and Respiratory Diseases: A New Therapeutic Strategy? [J]. Indian Journal of Microbiology, 2023, 63(1): 101-117.

Sponsors, Associates, and Links

---

• Journal of Neurobiology and Genetics
  
  
• Medical Imaging and Nuclear Medicine
  
  
• Bacterial Genetics and Ecology
  
  
• Transactions on Cancer
  
  
• Journal of Biophysics and Ecology
  
  
• Journal of Animal Science and Veterinary
  
  
• Academic Journal of Biochemistry and Molecular Biology
  
  
• Transactions on Cell and Developmental Biology
  
  
• Rehabilitation Engineering & Assistive Technology
  
  
• Orthopaedics and Sports Medicine
  
  
• Hematology and Stem Cell
  
  
• Journal of Intelligent Informatics and Biomedical Engineering
  
  
• MEDS Basic Medicine
  
  
• MEDS Stomatology
  
  
• MEDS Public Health and Preventive Medicine
  
  
• MEDS Chinese Medicine
  
  
• Journal of Enzyme Engineering
  
  
• Advances in Industrial Pharmacy and Pharmaceutical Sciences
  
  
• Bacteriology and Microbiology
  
  
• Advances in Physiology and Pathophysiology
  
  
• Journal of Vision and Ophthalmology
  
  
• Frontiers of Obstetrics and Gynecology
  
  
• Digestive Disease and Diabetes
  
  
• Advances in Immunology and Vaccines
  
  
• Nanomedicine and Drug Delivery
  
  
• Cardiology and Vascular System
  
  
• Pediatrics and Child Health
  
  
• Journal of Reproductive Medicine and Contraception
  
  
• Journal of Respiratory and Lung Disease
  
  
• Journal of Bioinformatics and Biomedicine